One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Diabetes, Obesity and Metabolism
doi : 10.1111/dom.15130
Diabetes, Obesity and Metabolism: Volume 26, Issue 5
Postprandial glucose-management strategies in type 1 diabetes: Current approaches and prospects with precision medicine and artificial intelligence
Adnan Jafar PhD, Melissa-Rosina Pasqua MD
doi : 10.1111/dom.15463
Inter-relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management
Jiten Vora MD, David Cherney MD, Mikhail N. Kosiborod MD, Jonas Spaak MD, Naresh Kanumilli MD, Kamlesh Khunti MD, Carolyn S. P. Lam MBBS, Michael Bachmann MSc, Peter Fenici MD, on behalf of the CaReMe Global Alliance
doi : 10.1111/dom.15485
Intermediate versus morning chronotype has lower vascular insulin sensitivity in adults with obesity
Steven K. Malin PhD, Mary-Margaret E. Remchak MS, Emily M. Heiston PhD, Daniel J. Battillo BS, Andrew J. Gow PhD, Ankit M. Shah MD, Zhenqi Liu MD
doi : 10.1111/dom.15456
A meta-analysis of diabetes risk prediction models applied to prediabetes screening
Yujin Liu, Sunrui Yu, Wenming Feng, Hangfeng Mo, Yuting Hua, Mei Zhang, Zhichao Zhu, Xiaoping Zhang, Zhen Wu, Lanzhen Zheng, Xiaoqiu Wu, Jiantong Shen, Wei Qiu, Jianlin Lou
doi : 10.1111/dom.15457
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective study
Yuta Nakamura MD, Ichiro Horie MD, Tadahiro Kitamura MD, Yoshiki Kusunoki MD, Kenro Nishida MD, Akane Yamamoto MD, Yushi Hirota MD, Tomoyasu Fukui MD, Yasutaka Maeda MD, Masae Minami MD, Takanori Matsui PhD, Atsushi Kawakami MD, Norio Abiru MD
doi : 10.1111/dom.15458
Renal outcomes with sodium-glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes: Analysis of medical administrative databases
Hiroaki Iijima PhD, Maki Gouda BSc (Agr.), Hideaki Hida PhD, Kazumi Mori-Anai PhD, Akiko Takahashi MS, Ryoichi Minai PhD, Hideki Ninomiya MD, Yoshiyuki Saito PharmD, Atsushi Miyawaki PhD, Jun Wada MD
doi : 10.1111/dom.15461
Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32-week randomized trial
Liv Vernstrøm MD, Søren Gullaksen PhD, Steffen S. Sørensen MD, Kristian L. Funck PhD, Esben Laugesen PhD, Per L. Poulsen DMSc
doi : 10.1111/dom.15464
Age- and gender-adjusted estimated glomerular filtration rate definition reveals hyperfiltration as a risk factor for renal function deterioration in type 2 diabetes
Wei-Lun Wen MD, Yau-Jiunn Lee PhD, Der-Wei Hwu MD, Yu-Hung Chang MD
doi : 10.1111/dom.15465
Baseline and change in serum uric acid level over time and resolution of nonalcoholic fatty liver disease in young adults: The Kangbuk Samsung Health Study
Yoosun Cho MD, Yoosoo Chang MD, Seungho Ryu MD, Sarah H. Wild PhD, Christopher D. Byrne MB BCh
doi : 10.1111/dom.15466
Higher early pregnancy plasma myo-inositol associates with increased postprandial glycaemia later in pregnancy: Secondary analyses of the NiPPeR randomized controlled trial
Shiao-Yng Chan MD. PhD, Han Zhang, Jui-Tsung Wong, Hsin F. Chang, Ling-Wei Chen, Sheila J. Barton, Heidi Nield, Sarah El-Heis, Timothy Kenealy, Luca Lavalle, J. Manuel Ramos-Nieves, Jean-Philippe Godin, Irma Silva-Zolezzi, Wayne S. Cutfield, Keith M. Godfrey, NiPPeR Study Group
doi : 10.1111/dom.15468
Saxagliptin/dapagliflozin is non-inferior to insulin glargine in terms of β-cell function in subjects with latent autoimmune diabetes in adults: A 12-month, randomized, comparator-controlled pilot study
Ernesto Maddaloni MD, Anda M. Naciu MD, Carmen Mignogna MD, Raffaele Galiero MD, Rocco Amendolara MSc, Marta Fogolari MD, Chiara Satta MD, Chiara Serafini MD, Silvia Angeletti MD, Maria Gisella Cavallo MD, Efisio Cossu MD, Ferdinando Carlo Sasso MD, Raffaella Buzzetti MD, Paolo Pozzilli MD, for the LADASAXADAPA study group
doi : 10.1111/dom.15469
Use of sodium-glucose cotransporter-2 inhibitors in France: Analysis of French nationwide health insurance database
Sibylle de Germay PharmD, Elodie Pambrun MSc, Antoine Pariente MD, Guillaume Grenet MD, Julien Bezin PharmD, Jean-Luc Faillie MD
doi : 10.1111/dom.15472
Association of patient characteristics and insurance type with anti-obesity medications prescribing and fills
Hamlet Gasoyan PhD, Elizabeth R. Pfoh PhD, Rebecca Schulte MPH, Erin Sullivan BS, Phuc Le PhD, Michael B. Rothberg MD
doi : 10.1111/dom.15473
Comparison of prediction models for cardiovascular and mortality risk in people with type 2 diabetes: An external validation in 23 685 adults included in the UK Biobank
Yikun Zhang MSc, Ong Xin Jiong MBBS, Shiqi Tang BSc, Yui Chit Tang MBBS, Cheuk Tung Wong MBBS, Carmen S. Ng PhD, Jianchao Quan MD
doi : 10.1111/dom.15474
Branched-chain amino acid levels are inversely associated with incident and prevalent chronic kidney disease in people with type 2 diabetes
Juliette A. de Klerk BSc, Roel Bijkerk PhD, Joline W. J. Beulens PhD, Anton Jan van Zonneveld PhD, Mirthe Muilwijk PhD, Peter P. Harms PhD, Marieke T. Blom PhD, Leendert M. 't Hart PhD, Roderick C. Slieker PhD
doi : 10.1111/dom.15475
Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial
Matthew P. Gilbert DO, Joan Skelly MS, Adrian F. Hernandez MD, Jennifer B. Green MD, Konstantin A. Krychtiuk MD, Christopher B. Granger MD, Lawrence A. Leiter MD, John J. V. McMurray MD, Stefano Del Prato MD, Richard E. Pratley MD
doi : 10.1111/dom.15479
Erythropoiesis and estimated fluid volume regulation following initiation of ipragliflozin treatment in patients with type 2 diabetes mellitus and chronic kidney disease: A post-hoc analysis of the PROCEED trial
Tatsuya Maruhashi MD, Atsushi Tanaka MD, Kanae Takahashi MPH, Yukihito Higashi MD, Koichi Node MD, on behalf of the PROCEED trial investigators
doi : 10.1111/dom.15481
ACAD10 is not required for metformin's metabolic actions or for maintenance of whole-body metabolism in C57BL/6J mice
Michael J. Yew BHealthSc (Hons), Sarah E. Heywood PhD, Joe Ng BHealthSc (Hons), Olivia M. West MSc, Martin Pal PhD, Andrew Kueh PhD, Graeme I. Lancaster PhD, Stephen Myers PhD, Christine Yang BSc (Hons), Yingying Liu MSc, Saskia Reibe PhD, Natalie A. Mellett BSc (Hons), Peter J. Meikle PhD, Mark A. Febbraio PhD, David W. Greening PhD, Brian G. Drew PhD, Darren C. Henstridge PhD
doi : 10.1111/dom.15484
IDegLira for the real-world treatment of type 2 diabetes in Italy. Final results from the REX observational study
Gian Paolo Fadini MD, Raffaella Buzzetti MD, Dario Pitocco MD, Elena Tortato MD, Alessia Scatena MD, Olga Lamacchia MD, Giusi Lastoria BSc, Lucia Simoni PhD, Agostino Consoli MD, on behalf of REX study group
doi : 10.1111/dom.15486
Impact of an online nutrition management application service on glycaemic management in individuals with diabetes: A propensity-score-matched retrospective cohort study
Junya Hironaka MD, Hiroshi Okada PhD, Megumi Minamida MD, Yuriko Kondo PhD, Hanako Nakajima PhD, Saori Majima PhD, Noriyuki Kitagawa PhD, Takuro Okamura PhD, Takafumi Senmaru PhD, Emi Ushigome PhD, Naoko Nakanishi PhD, Kazuki Hamada ME, Tetsuya Nojiri BA, Masahide Hamaguchi PhD, Michiaki Fukui PhD
doi : 10.1111/dom.15487
County-level socio-environmental factors and obesity prevalence in the United States
Pedro R. V. O. Salerno MD, Alice Qian BS, Weichuan Dong PhD, Salil Deo MD, Khurram Nasir MD, Sanjay Rajagopalan MD, Sadeer Al-Kindi MD
doi : 10.1111/dom.15488
TEAD1, MYO7A and NDUFC2 are novel functional genes associated with glucose metabolism in BXD recombinant inbred population
Yingying Wu MD, Chao Zhang MD, Shaofei Duan BD, Yushan Li BD, Lu Lu PhD, Akhilesh Bajpai PhD, Chunhua Yang PhD, Jia Mi PhD, Geng Tian PhD, Fuyi Xu PhD, Donglai Qi PhD, Zhaowei Xu PhD, Xiao Dong Chi PhD
doi : 10.1111/dom.15491
Retinal vascular density as a potential biomarker of diabetic cerebral small vessel disease
Yinqiong Huang PhD, Siyun Wang MD, Chi Cai MD, Xinwei Huang MD, Yan Chen MD, Xiaohong Wu MD, Yiping Zhang MD, Yan Zhang MD, Xiahong Lin PhD
doi : 10.1111/dom.15492
Use of once-daily oral semaglutide and associated clinical outcomes among adults with type 2 diabetes in routine clinical practice in Canada: A multicentre, prospective real-world study (PIONEER REAL Canada)
Akshay B. Jain MD, Sonja M. Reichert MD, Hanan Amadid MD, Uffe C. Braae PhD, Ryan M. Bradley PhD, James W. Kim MBBCh, Victoria Soo MD, Jean-François Yale FRCPC
doi : 10.1111/dom.15493
Association of serum magnesium with metabolic syndrome and the role of chronic kidney disease: A population-based cohort study with Mendelian randomization
Nuha Shugaa Addin MSc, Fiona Niedermayer MSc, Barbara Thorand PhD, Jakob Linseisen PhD, Jochen Seissler MD, Annette Peters PhD, Susanne Rospleszcz PhD
doi : 10.1111/dom.15497
Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trial
Mats C. Højbjerg Lassen MD, Niklas Dyrby Johansen MD, Daniel Modin MD, Joshua Nealon PhD, Sandrine Samson PhD, Marine Dufournet PhD, Matthew M. Loiacono PhD, Carsten Schade Larsen MD, Anne Marie Reimer Jensen MD, Nino Emanuel Landler MD, Brian L. Claggett PhD, Scott D. Solomon MD, Martin J. Landray PhD, Gunnar H. Gislason MD, Lars Køber MD, Jens Ulrik Stæhr Jensen MD, Pradeesh Sivapalan MD, Lasse Skafte Vestergaard MD, Tyra Grove Krause MD, Tor Biering-Sørensen MD
doi : 10.1111/dom.15498
Comparative analysis of hospitalization risk for incident heart failure in non-Hispanic Black versus non-Hispanic White individuals with type 2 diabetes on empagliflozin (Empa-AA): Insights from real-world data
Basem M. Mishriky MD, Doyle M. Cummings PharmD, Yuanyuan Fu MA, Jacqueline R. Halladay MD, Schuyler Jones MD, Andrea D. Boan PhD, Sara Jones MPH, Shivajirao P. Patil MD, James R. Powell MD, Alyssa Adams MPH, William Irish PhD
doi : 10.1111/dom.15499
Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta-analysis of cardiovascular outcome trials of novel glucose-lowering agents
Setor K. Kunutsor PhD, Francesco Zaccardi PhD, Victoria G. Balasubramanian PhD, Clare L. Gillies PhD, Vanita R. Aroda PhD, Samuel Seidu MD, Melanie J. Davies MD, Kamlesh Khunti PhD
doi : 10.1111/dom.15500
The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta-analysis of randomized controlled trials
Rachelle Haber RDN, Fatima Zarzour MD, Malak Ghezzawi BSc, Natalie Saadeh BSc, Dania S. Bacha MD, Lama Al Jebbawi MD, Marlene Chakhtoura MD, Christos S. Mantzoros MD
doi : 10.1111/dom.15501
Bridging dose of U-100 glargine with first dose of insulin degludec improves glycaemia in the 48 h after transition in twice-daily glargine users
Arthi Thirumalai MBBS, Jing H. Chao MD, Thanmai Kaleru MBBS, Xiaofu Dong MS, Patali Mandava MBBS, Dori Khakpour BS, Irl B. Hirsch MD
doi : 10.1111/dom.15502
Evaluating different low-density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study
Eric Yuk Fai Wan PhD, Wanchun Xu MPhil, Anna Hoi Ying Mok MClinPharm, Weng Yee Chin MD, Esther Yee Tak Yu MBBS, Celine Sze Ling Chui PhD, Esther Wai Yin Chan PhD, Ian Chi Kei Wong PhD, Cindy Lo Kuen Lam MD, Goodarz Danaei MD
doi : 10.1111/dom.15503
Insulin resistance before type 2 diabetes onset is associated with increased risk of albuminuria after diabetes onset: A prospective cohort study
Meeah R. Willig BS, Emma J. Stinson MPH, Helen C. Looker MBBS, Paolo Piaggi PhD, Cassie M. Mitchell PhD, Robert L. Hanson MD, Robert G. Nelson MD, Jonathan Krakoff MD, Douglas C. Chang MD
doi : 10.1111/dom.15505
Geographic and ethnicity variation in the prevalence of middle-aged and elderly adult obesity in China in 2020
Wen-Jun Tu MD, Zhenping Zhao PhD, Feng Yan MD, Xianwei Zeng MD, Jilai Li MD
doi : 10.1111/dom.15506
The number of nephroprotection targets attained is associated with cardiorenal outcomes and mortality in patients with diabetic kidney disease. The CKD-REIN cohort study
Fabrice Bonnet MD, Beverley Balkau PhD, Oriane Lambert BSc, Yakhara Diawara BSc, Christian Combe MD, Luc Frimat MD, Maurice Laville MD, Sophie Liabeuf PhD, Ziad A. Massy MD, Marie Metzger PhD, Bénédicte Stengel PhD, Natalia Alencar de Pinho PhD, Denis Fouque MD
doi : 10.1111/dom.15507
Associations of body mass index trajectory, waist circumference trajectory, or both with type 2 diabetes mellitus risk in Chinese adults: The China-PAR project
Yang Zhao PhD, Minghui Han PhD, Ranran Qie PhD, Yanyan Zhang PhD, Yuying Wu PhD, Xueru Fu PhD, Dongdong Zhang PhD, Lei Kuang PhD, Pei Qin PhD, Fulan Hu PhD, Jianxin Li PhD, Xiangfeng Lu PhD, Dongsheng Hu PhD, Ming Zhang MD … See fewer authorsÂ
doi : 10.1111/dom.15508
Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta-analysis
Leonardo A. Mesquita MD, Bernardo F. Spiazzi MD, Giovana F. Piccoli MD, Daniela A. Nogara MD, Gabriella R. da Natividade MD, Henrique I. Garbin MD, Laura F. Wayerbacher, Vanessa M. Wiercinski MD, Viviane A. Baggio MD, Carolina P. Zingano MD, Gilberto Schwartsmann MD, Gilberto Lopes MD, John R. Petrie FRCP, Verônica Colpani PhD, Fernando Gerchman MD … See fewer authorsÂ
doi : 10.1111/dom.15509
Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 1 diabetes
Ulrike Hövelmann MD, Susanne Engberg MD, Tim Heise MD, Niels Rode Kristensen PhD, Lea Nørgreen MSc, Eric Zijlstra PhD, Rasmus Ribel-Madsen PhD
doi : 10.1111/dom.15510
The effect of bolus advisors on glycaemic parameters in adults with diabetes on intensive insulin therapy: A systematic review with meta-analysis
Elisabeth J. den Brok MD, Cecilie H. Svensson MD, Maria Panagiotou MSc, Marleen M. J. van Greevenbroek PhD, Peter R. Mertens PhD, Andriani Vazeou PhD, Asimina Mitrakou PhD, Konstantinos Makrilakis PhD, Gregor H. L. M. Franssen MSc, Sander van Kuijk PhD, Stephan Proennecke PhD, Stavroula Mougiakakou PhD, Ulrik Pedersen-Bjergaard PhD, Bastiaan E. de Galan PhD, MELISSA consortium
doi : 10.1111/dom.15521
The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes
Yves Reznik MD, Elisabeth Bonnemaison MD, Guy Fagherazzi PhD, Eric Renard MD, Hélène Hanaire MD, Pauline Schaepelynck MD, Mihaela Mihaileanu MM, Jean-Pierre Riveline MD
doi : 10.1111/dom.15462
The critical role of abdominal obesity as a crucial cardiovascular risk factor
Salvatore Corrao MD, Luigi Calvo MD, Salvatore Amico MD, Christiano Argano MD
doi : 10.1111/dom.15467
Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post-hoc analysis of the EMMY trial
Caren Sourij MD, Abderrahim Oulhaj PhD, Faisal Aziz PhD, Norbert J. Tripolt PhD, Felix Aberer MD, Peter N. Pferschy MSc, Marek Postula MD, H. Drexel MD, Martin Benedikt MD, Ewald Kolesnik MD, Thomas R. Pieber MD, Heiko Bugger MD, Dirk von Lewinski MD, Harald Sourij MD
doi : 10.1111/dom.15477
Association of carpal tunnel syndrome with incident diabetes
Jeppe Ravn Jacobsen MB, Lucas Malta Westergaard MD, Emil L. Fosbøl PhD, Søren L. Kristensen PhD, Lars Køber DMSc, Frederik Persson DMSc, Peter Rossing DMSc, Rasmus Rørth PhD
doi : 10.1111/dom.15482
Uric acid-lowering effects of sodium-glucose cotransporter 2 inhibitors for preventing cardiovascular events and mortality: A systematic review and meta-analysis
A. Diallo MD, M. F. Diallo MD, M. Carlos-Bolumbu MD, F. Galtier MD
doi : 10.1111/dom.15483
Insights into the impact of sodium-glucose cotransporter 2 inhibition on urinary tract malignancy: A two-sample Mendelian randomization
Zeyu Han MD, Yazhou He PhD, Xue Li PhD, Sheyu Li PhD, Jianzhong Ai PhD
doi : 10.1111/dom.15490
Blood glucose control using a mobile health application in Singapore, Philippines and Hong Kong: a retrospective real-world data analysis
Yi Hui Tan, Wen Lee Tan MSc, Valerie Eichinger MSc, Bernhard Ruch PhD, Ester Yeoh MBBS, FRCP
doi : 10.1111/dom.15495
Insulin glargine 300 U/ml versus insulin degludec 100 U/ml improves nocturnal glycaemic control and variability in type 1 diabetes under routine clinical practice: A glucodensities-based post hoc analysis of the OneCare study
Fernando Gomez-Peralta PhD, Ana Chico Ballesteros PhD, Amparo Marco MartÃnez MD, Begoña Pérez Corral MD, Ignacio Conget Donlo PhD, Paulina Fuentealba Melo MD, Fernando Zaragozá Arnáez PhD, Marcos Matabuena RodrÃguez PhD
doi : 10.1111/dom.15496
